Click Here

Training Programs

1.0 Therapist Experiential and Guidance

2.0 Psilocybin-assisted Psychotherapy Guide

3.0 Psilocybin-assisted Psychotherapy Pilot Program

Begin your journey with the Academy's Continuing Education (CE) credited program -

Introduction to Psychedelic-assisted Psychotherapy

Becoming a trusted psychedelic therapist, sitter, guide, or coach isa sacred experience and provides a deep understanding of both the traditional use of the medicine and the psychological realities of the client's experience need to be recognized and honoured.

Introduction to Psychedelic-assisted Psychotherapy (PAP)

The ATMA ACADEMY PAA endorsed Introduction to Psychedelic-assisted Psychotherapy Program begins with re-defining the psychiatric model from one of “chemical imbalance” to one rooted in the mind-body-spirit dynamic that psychedelic therapeutic treatment can bring to the client.

It will include didactic material providing a basic understanding of the various psychedelic and entheogenic medicines currently in use, including Psilocybin, MDMA, LSD, Iboga, Ayahuasca, Ketamine, and other lesser known psychedelics.

Our teaching faculty for this program features a number of the leading authorities in their respective fields and areas of expertise, and are chosen from the following growing list of contributing luminaries:

Dr. Anthony Bossis: Guest Lecturer

Clinical Assistant Professor of Psychiatry

Paul Stamets

Mycologist, Researcher, Author and Entrepreneur

Dr. Rick Doblin

Founder and Executive Director, MAPS

Dr. Erika Dyck

Prof. & Canadian Research Chair, History of Medicine, U of Saskatchewan

Dr. Megan McElheran

Chief Clinician and CEO, Wayfound

Dr. Rakesh Jain

Jain Uplift

Dr. Saundra Jain

Adjunct Clinical Affiliate, U of Texas School of Nursing

Dr. Ian Mitchell

Emergency Physician and Associate Clinical Professor, UBC

Dr. Pamela Kryskow

Roots to Thrive

Bruce Sanguin

Psychotherapist

Françoise Bourzat

Center for Consciousness Medicine

Trevor Millar

Board Member, Canadian Psychedelic Association

David Harder

Co-Founder and Co-CEO, ATMA Journey Centers

Natalie Harder

Program Director, ATMA Journey Centers Inc.

Tarzie McLean

Psychotherapist and Owner of SoulCompass

Dr. Ravinder (Ravi) Bains

Chief Medical Officer, ATMA Journey Centers

Dr. Lyle Galloway, MD

Palliative Care Medical Advisor

Jane Cooper, MA

Transpersonal Psychotherapist

Dinesh Bhayana

Emergency & Addiction Physician, Board Member, MAPS

We are working with Health Canada to provide experiential training for participants to experience the medicine journey through a clinical trial. These guided psilocybin sessions will take place at our Urban Clinic locations, and we will be announcing the timelines and details as soon as we receive confirmation from Health Canada.

Introduction to Psychedelic-assisted Psychotherapy (PAP) MODULES

Introduction to Psychedelic Assisted Therapy

Introduction to Psychedelic Assisted Therapy

  • Introductions, setting the direction and space for the course
  • A history of Psychedelics

Ethics in Psychedelic Psychotherapy

  • Ethics in Psychedelic Assisted Psychotherapy

Hands-On Work and Practical Consideration

  • How to set up the space for effective therapy
  • Nuts and bolts of Psychedelic therapy: Forms, intake, screening and processes

Ketamine, LSD, and Other Psychedelic Medicine:

  • Therapy and uses
  • Dosing, methods of consumption, other considerations

Sitters/Guides/Therapists Roles

  • Past and current models of therapy with psychedelic medicines
  • The art of the sitter and guide

MDMA and Psilocybin Treatment

  • Applications and uses
  • Dosage, treatment and other consideration

Palliative Care with Psychedelic-assisted Psychotherapy

  • MDMA-assisted therapy and uses
  • Applications and considerations for therapy

Integration

  • Exploration of different models of integration

What's included in your training

>

16 sections in 8 modules;

>

Interactive Zoom classes for those not in Calgary;

>

Live classroom setting in Calgary (as COVID guidelines allow);

>

Consideration and inclusion in the experiential clinical trial program;

>

Optional and per Health Canada’s approvals ongoing:
Hands-on training with real-world clients for select approved therapists with clients following the training.

Frequently Asked Questions

This training is designed to help practicing counsellors, psychologists, psychiatrists and medial professionals gain a basic understanding of psychedelic therapy. This work can support other modalities that you may already facilitate with clients (such as IFS, somatic therapy, EMDR, breathwork, etc). It is not intended to replace what you feel already works, but to provide you with additional, science-based tools to enhance your current practice.

Coming out of this course, you will have a basic understanding of:

  • The various psychedelic medicines in use today;
  • How to best set up a session with a client in psychedelic therapy;
  • Some of the legal and ethical issues that need to be considered when using psychedelic psychotherapy;
  • A sense of how and for which applications these medicines work; and
  • A clear path on what is required in order for you to introduce this work to your practice when these medicines become legalized.
This is not a mandatory component of the training, but we believe that one of the most important elements of working with psychedelic-assisted therapy is to have first-hand experience with the medicine. We are working closely with Health Canada to find the right way to safely provide this as an option to each student enrolled in the course. This experiential understanding is, we believe, essential to being a qualified therapist to provide psychedelic therapy, to more empathetically understand what the client is experiencing.
We are currently working with Health Canada to find a pathway forward to be able to offer an experiential aspect to the training. We are hopeful that this will be resolved very soon through the Clinical Trial Application currently in the approval process, and will be updating this site and making announcements when we are able to confirm this piece.
We are developing a course specifically for non-registered Healthcare Workers and will be working with Health Canada to educate and equip Health Care Professionals. Subscribe to our therapist training email list for continued updates.
This training course draws from a lineup of exceptionally qualified and experienced instructors in the psychedelic field. You will meet and interact with some of the leading minds and voices in psychedelic medicine from Canada and beyond, giving you a deep insight into the historical, present and future applications of this important work. We are confident that the training will, in the limited time allowed, provide a solid understanding of each of the given areas of study.
Yes! We have a partnership with the Psychologists Association of Alberta, and have CE credits available for eligible professionals.
As you are likely aware, we are in a state of significant change in Canada with regard to psychedelics. Health Canada is opening the door slowly to patients to access these medicines, but we believe it will be a matter of at least some months if not a year or two before these medicines are fully accessible for therapists to offer their clients. At ATMA, we are preparing for these medicines to become legal for therapy, and believe that those who are qualified therapists, together with an understanding of the medicines, will be at the forefront of the leading edge therapy protocols in the future. Psychedelic medicine will have a significant impact on treatment and therapy options for mental health, PTSD, and addictions. Now is the time to fully educate oneself as a therapist to be ready for the wave of need for therapists that is coming.
As you are likely aware, we are in a state of significant change in Canada with regard to psychedelics. Health Canada is opening the door slowly to patients to access these medicines, but we believe it will be a matter of at least some months if not a year or two before these medicines are fully accessible for therapists to offer their clients. At ATMA, we are preparing for these medicines to become legal for therapy, and believe that those who are qualified therapists, together with an understanding of the medicines, will be at the forefront of the leading edge therapy protocols in the future. Psychedelic medicine will have a significant impact on treatment and therapy options for mental health, PTSD, and addictions. Now is the time to fully educate oneself as a therapist to be ready for the wave of need for therapists that is coming.
Yes! All sessions are recorded and are available after the evening is complete. If you must miss a class, you can catch up when it works best for you. You can also go back to review material that you found interesting and want to rediscover. Videos are saved under the main header of each training session.
With the current restrictions in place with the COVID 19 Pandemic Situation, there are NO in person events. We follow all government guidelines based in Alberta, and will update this as restrictions change.